Rules ‘blocking cheaper drugs’
PATIENTS are being denied life-saving medicines because SA’s patent regime allows multinational companies to block cheaper generic rivals and stifle competition, according to a new report.
PATIENTS are being denied life-saving medicines because SA’s patent regime allows multinational companies to block cheaper generic rivals and stifle competition, according to a new report.